STENOCARE Completes Integration of CannGros ApS
Medical cannabis company STENOCARE A/S has finalized the integration of CannGros ApS, acquired in November 2025. The move aims to strengthen STENOCARE's position in the Danish medical cannabis market.
Danish medical cannabis company STENOCARE A/S announced the successful completion of its integration of CannGros ApS by the end of June 2026. CannGros ApS was acquired in November 2025 to bolster STENOCARE's market presence in Denmark.
The integration process proceeded as planned, involving several successful cycles of import, repackaging, and sales. The corporate merger has been finalized, and process optimizations have been implemented to reduce both costs and lead times.
The acquisition of CannGros ApS was strategic for strengthening STENOCARE's position within the growing Danish medical cannabis sector. The integration is expected to enhance the company's operational efficiency and local supply capabilities.
STENOCARE is listed on the NASDAQ First North Growth Market under the ticker STENO.